eplerenone
UkraineDrugs containing this active substance
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease and mortality in patients with left ventricular dysfunction and signs of heart failure following myocardial infarction, as well as in adults with Class II chronic heart failure.
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease and mortality in adult patients with left ventricular dysfunction and signs of heart failure following myocardial infarction, as well as in class II chronic heart failure.
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality associated with cardiovascular problems in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in Class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: Adamed Pharma S.A. (manufacturing of unpackaged products, primary and secondary packaging, quality control, batch release)
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality associated with cardiovascular problems in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: Adamed Pharma S.A. (manufacturing of unpackaged products, primary and secondary packaging, quality control, batch release)
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease and fatal outcomes in patients with left ventricular dysfunction and signs of heart failure (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is prescribed as an adjunct to standard therapy to reduce the risk of cardiovascular disease and fatal outcomes in patients with left ventricular dysfunction and signs of heart failure (specifically following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease in adults with heart failure. Specifically, it is prescribed to patients with left ventricular dysfunction following a recent myocardial infarction or in chronic heart failure class II.
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease and fatal outcomes in adults with heart failure (specifically following myocardial infarction or in chronic heart failure with certain signs of left ventricular dysfunction).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality from cardiovascular problems in adults with heart failure or following myocardial infarction.
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: Laboratorio Dr. F. Echevarne, Analisis, S.A. (alternative unit for conducting analytical tests)
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality from cardiovascular problems in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: Laboratorio Dr. F. Echevarne, Analisis, S.A. (alternative unit for conducting analytical tests)
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular morbidity and mortality in adults with heart failure and impaired left ventricular function (following myocardial infarction or in chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: Synthon Hispania, S.L. (manufacturing, primary, secondary packaging, quality control, batch release)
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular morbidity and mortality in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: Synthon Hispania, S.L. (manufacturing, primary, secondary packaging, quality control, batch release)
-
The drug is used as an adjunct to standard treatment to reduce the risk of cardiovascular disease and fatal outcomes in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in NYHA Class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
-
The drug is used as an adjunct to standard treatment to reduce the risk of morbidity and mortality from cardiovascular disease in patients with heart failure and left ventricular dysfunction.
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: Pharmaceutical Plant "Polpharma" S.A.
-
The drug is prescribed as an adjunct to standard therapy to reduce the risk of cardiovascular disease and fatal outcomes in adults with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: Pharmaceutical Plant "Polpharma" S.A.
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality in patients with heart failure and left ventricular dysfunction, particularly following myocardial infarction.
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: Viatris Pharmaceuticals LLC (manufacturing of drug substance in bulk, and quality control)
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality in adult patients with heart failure and left ventricular dysfunction, particularly following a recent myocardial infarction.
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: Viatris Pharmaceuticals LLC (manufacturing of drug substance in bulk, and quality control)
-
The drug is indicated as an adjunct to standard therapy to reduce the risk of morbidity and mortality in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: PJSC "Kyivmedpreparat" (packaging from bulk of manufacturer Adamed Pharma S.A., Poland)
-
The drug is used as an adjunct to standard therapy to reduce the risk of morbidity and mortality in patients with heart failure and left ventricular dysfunction, particularly following myocardial infarction.
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: PJSC "Kyivmedpreparat" (packaging from bulk of manufacturer Adamed Pharma S.A., Poland)
-
The drug is prescribed as an adjunct to standard therapy to reduce the risk of morbidity and mortality in patients with heart failure and left ventricular dysfunction, particularly following myocardial infarction.
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease and fatal outcomes in patients with heart failure and left ventricular dysfunction (particularly following a myocardial infarction).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease and fatal outcomes in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in Class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 25 mg ATC: C03DA04
-
The drug is used as an adjunct to standard therapy to reduce the risk of cardiovascular disease and fatal outcomes in patients with heart failure and left ventricular dysfunction (following myocardial infarction or in class II chronic heart failure).
Form: tablets, film-coated
Active substance Dosage eplerenone 50 mg ATC: C03DA04